Double Setback for Gilead - Analyst Blog
4/30/2013 3:47:55 PM - Zacks.com
United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
4/30/2013 4:19:00 AM - Seeking Alpha
Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million Compensation
4/29/2013 2:49:00 PM - Dow Jones Business News
FDA Reject NDAs For Two Gilead HIV Drugs - Update
4/29/2013 2:27:00 PM - RTT News
UPDATE: Gilead Says FDA Rejects New Drug Applications for HIV Drugs
4/29/2013 11:36:00 AM - Dow Jones Business News
Gilead Says FDA Rejects New Drug Applications for Elvitegravir, Cobicistat
4/29/2013 9:09:00 AM - Dow Jones Business News
FDA Rejects Gilead Sciences' NDAs For Elvitegravir And Cobicistat - Quick Facts
4/29/2013 8:44:00 AM - RTT News
A Look Ahead: This Week's ETFs to Watch
4/28/2013 5:28:16 PM - Benzinga
S&P 500 Q1 Earnings Seem Positive: Is It Enough For More Gains?
4/28/2013 2:51:00 AM - Seeking Alpha
After Hours Most Active for Apr 26, 2013 : STX, CMCSA, BAC, NTAP, VZ, QQQ, GILD, INTC, APC, GE, AXP, PFE
4/26/2013 4:44:49 PM - NASDAQ.com News
Buzz on the Street: Apple Earnings, a Hijacked AP, and the Telltale VIX Make for One Wacky Week
4/26/2013 2:00:00 PM - Minyanville
As Biotechnology Stocks Soar, Bubble Talk Percolates
4/26/2013 9:27:00 AM - Dow Jones Business News
Cramer's Mad Money - Why Analysts Were Wrong About Microsoft (4/25/13)
4/26/2013 7:20:00 AM - Seeking Alpha
Cramer's Top Stock Picks: GILD GOOG BA MSFT BWLD
4/26/2013 6:00:00 AM - TheStreet
Is the Biotech Sector Still a Market Leader? - Real Time Insight
4/25/2013 11:18:48 AM - Zacks.com
Cramer's Mad Money - National Lemming Day (4/24/13)
4/25/2013 6:52:00 AM - Seeking Alpha
Gilead Reports Encouraging HCV Data - Analyst Blog
4/24/2013 7:10:53 PM - Zacks.com
Stocks End Mixed Today; Dow Snaps Three-Day Rally
4/24/2013 4:29:00 PM - Knobias
Amgen's Quarter Sucked, But Keep Buying Biotech Stocks, Analysts Urge (Updated)
4/24/2013 3:59:00 PM - TheStreet
Investors May Want To Fade Healthcare In May
4/24/2013 1:53:00 AM - Seeking Alpha
Will Eli Lilly Beat Earnings in 1Q? - Analyst Blog
4/23/2013 5:11:25 PM - Zacks.com
Bristol Still Playing Catch-Up to Gilead in Hep C Drug Race
4/23/2013 10:44:00 AM - TheStreet
Bristol Says Results of Hepatitis C Drug Trial are Positive
4/23/2013 6:14:00 AM - Dow Jones Business News
Will Amgen Beat Earnings? - Analyst Blog
4/22/2013 5:11:30 PM - Zacks.com
Bristol-Myers Likely to Report In Line Earnings - Analyst Blog
4/22/2013 4:09:40 PM - Zacks.com
